Navigation Links
Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT
Date:9/17/2008

WALTHAM, Mass., Sept. 17 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will present at the 2008 UBS Global Life Sciences Conference on Wednesday, September 24, 2008 at 1:00 p.m. EDT at the Grand Hyatt Hotel, 455 Madison Avenue, New York, NY.

A live audio-webcast of the presentation will be available via Repligen's website at http://www.repligen.com and will be archived for 30 days following the presentation.

About Repligen Corporation

Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for diseases that affect the central nervous system. In addition, we are the world's leading supplier of recombinant Protein A, the sales of which partially fund the advancement of our development pipeline while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Additional information may be requested from http://www.repligen.com.

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical statements, including, without limitation, statements regarding current or future financial performance and position, managem
'/>"/>

SOURCE Repligen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
2. Repligen Receives Research Grants to Support Friedreichs Ataxia Development Program
3. Repligen Announces Conference Call of First Quarter Fiscal Year 2009 Results
4. Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results
5. Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit
6. Repligen Announces Conference Call of Third Quarter Fiscal Year 2008 Results
7. Dendreon Announces Webcast Presentation at UBS Global Life Sciences Conference
8. AEterna Zentaris to Present at Upcoming CIBC World Markets 7th Annual Eastern Investor Conference
9. Sinovac to Present at the 2008 UBS Global Life Sciences Conference
10. Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference
11. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...he Netherlands, December 2 Pepscan...ompany focusing on protein mimicking,technology fo...unced that it,has appointed Wim E.M. Mol, Ph.D. as...ill be responsible for all of Pepscans corporate f...direction of the company. He brings to,Pepscan mor...
(Date:12/2/2009)...ALEM, Israel, December 2 Gamida Ce...the preclinical (animal study) safety and,efficacy...gy from Weill,Cornell Medical College and Gamida C...ited anemias such as Cooley,s Anemia. , G...to expand, ex vivo,populations of stem/progenitor...
(Date:12/2/2009)...a., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald ...C Bulletin Board: EMDY), a leading,producer and di...owder and,soybean products in China, today announc... issue of US Food & Drink Executive, a quarter...utives in the food and beverage industry. , ...
(Date:12/2/2009).... 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc....bal biopharmaceutical company focused on endocrine...S. Food and Drug Administration (FDA) has granted ...pathway inhibitor compound, perifosine (KRX-0401),... myeloma. Keryx Biopharmaceuticals, Inc. ("Keryx")...
Breaking Biology Technology:Dutch Biotech Company Pepscan Appoints New CEO 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...ces now offers,the LI-COR Blot Washer for automati...ry antibody addition for Western blots. Providing ... for one or multiple blots, the,LI-COR Blot Washer...instrument featuring user-defined, preset wash cyc...sher memory with 1 to 4 individually configurable,...
...your tastes tend,toward bright lights and big citi... around the U.S. are gearing up to celebrate World...hreat of diabetes., The International Diabetes Fe...ited Nations to recognize the existing World Diabe... announced that this year,s,campaign theme is "Dia...
...rstCall/ -- American Oriental,Bioengineering, Inc....ibutor,and manufacturer of pharmaceutical and heal... Company will present at the following conferences...nce, held at the Waldorf- Astoria in New York.... 8:40 am ET on Tuesday, November 4, 2008., -- ...
Other Biology Technology:LI-COR Blot Washer Automates Western Blot Processing 2From Race Cars and Google Doodles to Day Spas and Night Lights: Groups Across the U.S. Prepare to Join World Diabetes Day Celebrations on November 14 2From Race Cars and Google Doodles to Day Spas and Night Lights: Groups Across the U.S. Prepare to Join World Diabetes Day Celebrations on November 14 3From Race Cars and Google Doodles to Day Spas and Night Lights: Groups Across the U.S. Prepare to Join World Diabetes Day Celebrations on November 14 4American Oriental Bioengineering Announces Participation in November Investor Conferences 2
(Date:12/1/2009)...vailable in German . , Brown adipose tissue i... of mitochondria, miniature power stations which ...they normally generate a voltage similar to that o...ar processes. However, the mitochondria of brown f...ahead all the time. The energy released when the f...
(Date:12/1/2009)...ists, one from the United States, the other from C...der of his wolf pack, on remote Ellesmere Island, ... finally find out what these "North Pole wolves" d...arshest areas of the world., "We first encounter...h, a renowned U.S. Geological Survey (USGS) wolf r...
(Date:12/1/2009).... -- Time-lapsed video of individual breast tissue...fe of a cell: a protein that cycles between two ma...earchers a more complete view of the internal sign... that go awry in cancer and are targets of drug de... respond to growth factors, travels back and forth...
Breaking Biology News(10 mins):Brown fat cells make 'spare tires' shrink 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4Traveling With Diabetes The Positive Way 55962 1Traveling With Diabetes The Positive Way 55962 2Traveling With Diabetes The Positive Way 55962 3Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 1Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 2Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 3Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 4Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 5SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 1SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 2SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 3SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 4SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 5SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 6SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 7SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 8SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 9
...Columbia University,s Mailman School of Public Hea...nd developed a sensitive new diagnostic technology...eously screen for multiple infectious agents. The ...n the February issue of the Centers for Disease Co...iseases. This new platform is demonstrated in an a...
... Duke University Medical Center researchers as to ... new approach for developing HIV vaccines. The fin...cause they induce a class of antibodies that a pat... , The Duke team discovered that certain broadly ...nto the HIV protein gp41, resemble antibodies made...
...taste receptor gene influences taste sensitivity o...ifferences in taste preferences and food selection...mical Senses Center. In addition to genes, age and...times overriding the influence of genetics. , The...e more attracted to sweet-tasting foods, as well a...
Other Biology News:Researchers develop rapid diagnostic tool for pathogen identification 2New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines 2New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines 3Children's taste sensitivity and food choices influenced by taste gene 2Children's taste sensitivity and food choices influenced by taste gene 3
Concentrated Epitope Retrieval Buffer-Reduced pH from Bethyl Laboratories
GIBCO Donor Calf Serum from Invitrogen
...agicMark XP Western Protein Standards are specific...cular weight estimation directly on western blots....e, allowing direct visualization with the same ant...t protein on the blots. Colorimetric, chemilumines...
Genetic Mapping of Disease Genes from Promega
Biology Products: